Cargando…
Consideration in Selection of the Control Group in Diagnostic Tests
Autores principales: | Cui, Jianlan, Zhao, Naiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509334/ https://www.ncbi.nlm.nih.gov/pubmed/23197938 http://dx.doi.org/10.7150/ijbs.5459 |
Ejemplares similares
-
The Efficacy of Bevacizumab Compared with Other Targeted Drugs for Patients with Advanced NSCLC: A Meta-Analysis from 30 Randomized Controlled Clinical Trials
por: Cui, Jianlan, et al.
Publicado: (2013) -
Practical considerations for DNA fragmentation testing in the management of male fertility
por: Kovac, Jason R.
Publicado: (2017) -
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
por: Abid, Muhammad Bilal
Publicado: (2021) -
Further considerations for placebo controls in surgical trials
por: Campbell, Marion K., et al.
Publicado: (2023) -
c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Yu, Shan, et al.
Publicado: (2013)